Positron Announces Installation of Their AttriusTM PET Scanner into the Heart Center of Niagara, New York

      

The Attrius is the only PET scanner offered on the market today that is optimized for myocardial perfusion imaging. The Attrius is a standalone full ring PET system, manufactured through Positron's joint venture, Neusoft Positron Medical Systems Co., Ltd.

Tim Gabel, Positron's Vice President of Engineering and Operations stated, "It is exciting to see our vision of a dedicated cardiac PET scanner come to fruition. We are confident that our long term customers, like Dr. Merhige, will be pleased to see that their feedback and suggestions have been implemented into the design of the Attrius and that our new customers will enjoy the benefit of over 25 years of experience in clinical PET that the Attrius^TM has to offer.

Michael E. Merhige, M.D., Director of the Heart Center of Niagara and Medical Director of Positron stated, "The Attrius^TM is optimized specifically for cardiac imaging, both with generator produced Rb-82, as well as cyclotron produced perfusion tracers. It avoids the layering on of expensive CT technology, which is unnecessary in cardiac PET perfusion imaging and it offers the most advanced cardiac perfusion software, already clinically validated, as standard equipment. Dr. Merhige went on to state, "Positron's Attrius^TM fills a critical vacuum in the care of coronary disease patients, namely the absence of an affordable, optimally accurate, noninvasive perfusion imaging system, which can guide medical and interventional therapy in individual patients. These features and others position the Attrius^TM PET system as a replacement for SPECT perfusion imaging"

About Positron: Positron is a molecular imaging company focused on Nuclear Cardiology. Positron utilizes its proprietary product line to provide unique solutions to the Nuclear Medicine community ranging from imaging to radiopharmaceutical distribution. Positron products include: the Attrius , a PET imaging device; the Pulse, a SPECT imaging device; the Nuclear Pharm-Assist, an automated radiopharmaceutical distribution device; and the Tech-Assist , a radiopharmaceutical injection shield. More information about Positron is available at www.positron.com.

Forward Looking Statements: Statements in this document contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended. These statements are based on many assumptions and estimates and are not guarantees of future performance and may involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Positron Corporation to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. Our actual results may differ materially from the results anticipated in these forward-looking statements due to a variety of factors, including, without limitation those set forth as "Risk Factors" in our filings with the Securities and Exchange Commission.

Positron Corporation
Joe Oliverio, (317)576-0183